poisar

Stocks · News reference

OKYO Pharma Says Chairman Gabriele Cerrone, Through Panetta Partners, Increases His Holdings With Purchase Of 25,000 Ordinary Shares At $1.40 Per Share

Jul 21, 2026, 11:03 AMBenzinga Newsdesk

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

OKYO
Source
benzinga
Observed
Jul 21, 2026, 11:03 AM
Checked
Jul 21, 2026, 11:03 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading